Wednesday, March 26, 2014 | Sanford Consortium for Regenerative Medicine
2880 Torrey Pines Scenic Drive
La Jolla, CA 92037

5:30 to 8:00 PM

Forty years ago, DNA sequencing was a laborious and costly process that produced only a few kilobytes of sequence data in a week. But then the world changed.

The invention of automated sequencers in the 1980s enabled the completion of the Human Genome Project, and a subsequent generation of instruments developed in the 1990s laid the foundation for personalized medicine.

Today, researchers can generate gigabytes of sequence data in hours for a few thousand dollars. We are rapidly approaching the point where whole genome sequencing can be performed economically at the point-of-care in physicians’ offices.

Panelists will explore such questions as:

• What did it take to develop the first generation machines?
• Where has the next generation taken us?
• Where can we expect to go in the future?

Moderator:
David Hale, Chairman and CEO, Hale BioPharma Ventures, LLC

Panelists:

Jay Flatley, President and CEO, Illumina
Greg Lucier, Chairman and CEO, Life Technologies
J. Craig Venter, Founder, Chairman and CEO, J. Craig Venter Institute

Agenda:
5:30 – 7:00 p.m. Discussion
7:00 – 8:00 p.m. Reception

RSVP by Tuesday, March 25, 2014 12:00 p.m.

Sanford Consortium for Regenerative Medicine
2880 Torrey Pines Scenic Drive
San Diego, CA 92121
Map and Directions